IP Library Granted Patent US 9,216,184
Granted Patent B1
US 9,216,184 · App. 14/280,571 · Granted Dec 22, 2015

Agent and method for increasing testosterone level in a body

Inventors: Roman Anatolievich Trunin (Moscow, RU); Evgenii Iljich Maevskii (Pushino, RU); Mikhail Lvovich Uchitel (Mytishi, RU)
Assignee: Lunada Biomedical, LLC
A61K31/593A61K31/194A61K31/197A61K31/198A61K31/315A61K31/355A61K31/375
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,216,184
App. No.
14/280,571
Granted
Dec 22, 2015
Kind
B1
Abstract

A composition for regulating male sexual function includes at least one amino acid selected from a group consisting of L-Glutamic acid (glutamate), L-Arginine, glycine, L-aspartate, L-carnitine, L-tyrosine, L-glutamine and/or its pharmaceutically acceptable salt, such as any of monosodium-L-glutamate monogidrate, L-potassiumarginine, L,-ammoniumaspartate, L-arginine HCl, sodium-L-tyrasine, lithium aspartate, in the amount of 1-1000 mg, preferably 10-300 mg; at least one vitamin, in the amount of 1-500% of a daily recommended dose, preferably 10-200%; and at least one chelated compound of a formula: acid-Me-acid.nH 2 O, wherein Me is a metal chosen from any of Ca, Mg and Zn, wherein the acid is a dicarboxylic acid anion chosen from the group consisting of succinic acid, fumaric acid or aspartic acid, and wherein n=0-8. The composition increases testosterone level in a body of a male mammal.

Claims (31)

1. A non-steroidal composition for regulating male sexual function, comprising:

at least one amino acid in an amount of 1-1000 mg and selected from a group consisting of L-Glutamic acid (glutamate), L-Arginine, glycine, L-aspartate, L-carnitine, L-tyrosine, L-glutamine, monosodium-L-glutamate monohydrate, L-potassiumarginine, L-ammoniumaspartate, L-arginine HCl, sodium-L-tyrosine, and lithium aspartate;

at least one vitamin, in the amount of 1-500% of a daily recommended dose; and

at least one chelated compound of a formula: R1-Me-R2.nH 2 O,

wherein Me is a metal chosen from any of Ca, Mg and Zn,

wherein R1 is a dicarboxylic acid anion chosen from a group consisting of succinic acid, fumaric acid or aspartic acid,

wherein R2 is a dicarboxylic acid anion chosen from the group consisting of succinic acid, fumaric acid or aspartic acid,

wherein R1 is the same as R2, and

wherein n=0-8.

2. The composition of claim 1 , further comprising at least one monoammonium and/or diammonium salt of a dicarboxylic acid chosen from succinic or fumaric acid, in the amount of 20-5000 mg.

3. The composition of claim 1 , wherein the composition increases testosterone level in pathologies that cause suppression of testosterone synthesis, including hypogonadism.

4. The composition of claim 1 , further comprising any of (i) sugar, (ii) starch, (iii) casein, (iv) microcellulose, (v) inert compounds, including any of dry mil, activated coal, flour and fillers, (vi) calcium stearate, (vii) stearic acid, (viii) magnesium stearate, (ix) talcum, and (x) mixture of (i)-(ix) as excipients.

5. The composition of claim 1 , wherein the composition increases testosterone level in a body of a male mammal.

6. The composition of claim 1 , wherein the composition is in a form of a powder, granules, tablets or capsules.

7. The composition of claim 5 , wherein the composition is in a form of a set of two powders, granules, tablets or capsules.

8. A method for regulating male sexual function, the method comprising:

providing a single administration of 100-20000 mg of a composition of claim 1 .

9. The method of claim 7 , further comprising providing a course of treatment lasting from 3 to 90 days with daily taking of 10-20,000 mg of the composition one or more times.

10. The method of claim 8 , wherein a number of courses is unlimited.

11. The composition of claim 1 , wherein Me is Ca or Mg.

12. The composition of claim 1 , wherein Me is Ca.

13. The composition of claim 1 , wherein Me is Mg.

14. The composition of claim 1 , wherein the at least one amino acid is selected from a group consisting of L-Glutamic acid (glutamate), glycine, L-aspartate, L-tyrosine, L-glutamine, monosodium-L-glutamate monohydrate, L-potassiumarginine, L-ammoniumaspartate, and sodium-L-tyrasine, and lithium aspartate.

15. A non-steroidal composition for regulating male sexual function, comprising:

at least one amino acid in an amount of 1-1000 mg and selected from a group consisting of L-Glutamic acid (glutamate), L-Arginine, glycine, L-aspartate, L-carnitine, L-tyrosine, L-glutamine, monosodium-L-glutamate monohydrate, L-potassiumarginine, L-ammoniumaspartate, L-arginine HCl, sodium-L-tyrosine and lithium aspartate;

at least one vitamin, in the amount of 1- 500% of a daily recommended dose; and

at least one chelated compound R1-Ca—R2.nH 2 O,

wherein R1 is succinic acid, fumaric acid or aspartic acid,

wherein R2 is succinic acid, fumaric acid or aspartic acid,

wherein R1 is the same as R2, and

wherein n is no greater than 8.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2020
From: TRUNIN, ROMAN ANATOLIEVICH
To: AMBER IP, LLC
Reel/Frame 053844/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2018
From: LUNADA BIOMEDICAL, LLC
To: TRUNIN, ROMAN ANATOLIEVICH
Reel/Frame 046408/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2014
From: TRUNIN, ROMAN ANATOLIEVICH; UCHITEL, MIKHAIL LVOVICH; MAEVSKII, EVGENII ILJICH
To: LUNADA BIOMEDICAL, LLC
Reel/Frame 032918/0929 →
Continuity (1)
Provisional Application 61834453 · Jun 13, 2013